Voriconazole versus natamycin as primary treatment in fungal corneal ulcers

Clinical and Experimental Ophthalmology

Volumn 39, Issue 5, 2011, Pages 434-440

  Arora, Ritu ^a   Gupta, Deepa ^a   Goyal, Jawaharlal ^a   Kaur, Ravinder ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Fungal keratitis; Natamycin; Voriconazole

Indexed keywords

NATAMYCIN; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ASPERGILLUS; BACTERIUM ISOLATE; CATARACT EXTRACTION; CLINICAL ARTICLE; CORNEA ULCER; CURVULARIA; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; INTERVENTION STUDY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KERATOMYCOSIS; PENETRATING KERATOPLASTY; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENILE CATARACT; ULCER HEALING; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; CORNEAL ULCER; DOUBLE-BLIND METHOD; EYE INFECTIONS, FUNGAL; FEMALE; FUNGI; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; MYCOSES; NATAMYCIN; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; PROSPECTIVE STUDIES; PYRIMIDINES; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; VISUAL ACUITY;

EID: 79960232609     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02473.x     Document Type: Article

References (33)

1. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 321-7.
2. Galaretta D, Tuft S, Ramsay A, Dart J. Fungal keratitis in London: microbiological and clinical evalution. Cornea 2007; 26: 1082-6.
3. Upadhyay MP, Karamcharya PC, Koirala S etal. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991; 111: 92-9.
4. Dunlop AA, Wright ED, Howlader SA etal. Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol 1994; 22: 105-10.
5. Hagan M, Wright E, Newman M etal. Causes of suppurative keratitis in Ghana. Br J Ophthalmol 1995; 79: 1024-8.
6. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994; 101: 1005-13.
7. Srinivasan M, Gonzales CA, George C etal. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997; 81: 965-71.
8. Bhartiya P, Daniell M, Constantinou M, Islam F, Taylor H. Fungal keratitis in Melbourne. Clin Experiment Ophthalmol 2007; 35: 124-30.
9. Manzouri B, Vafidis G, Wyse R. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother 2001; 2: 1849-57.
10. O'Day DM. Selection of appropriate antifungal therapy. Cornea 1987; 6: 238-45.
11. Jones DB, Forster RK, Rebell G. Fusarium solani keratitis treated with natamycin. Arch Ophthalmol 1972; 88: 147-54.
12. Lalitha P, Prajna N, Kabra A, Mahadevan K, Srinivasan M. Risk Factors for treatment outcome in Fungal Keratitis. Ophthalmology 2001; 113: 526-30.
13. Espinel-Ingrofff A, Boyle K, Sheehan DJ. In vitro antifungal activities of Voriconazole and reference agents as determined by NCCLS methods; review of the literature. Mycopathologia 2001; 150: 101-15.
14. Ghannoum MA, Kuhn DM. Voriconazole: better chances for patients with invasive mycoses. Eur J Med Res 2002; 7: 242-56.
15. Marco F, Pfaller MA, Messer SA etal. Antifungal activity of a new triazole, voriconazole (UK-109, 496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 1998; 36: 433-6.
16. Sabo JA, Abdel- Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother 2000; 34: 1032-43.
17. Maragon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004; 137: 820-5.
18. Bunya VY, Hammersmith KM, Rapuano CJ, Ayres BD, Cohen EJ. Topical and oral voriconazole in treatment of fungal keratitis. Am J Ophthalmol 2007; 143: 151-3.
19. Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea 2003; 22: 33-6.
20. Horstkotte MA, Weibmann J, Engelmann K, Garner JC, Sobottka I. Sucessful treatment of ulcerating keratitis due to Acremonium recifei with voriconazole. ESCMID 2007: Abstract no.1134-01-345.
21. Stewart RMK, Quah SA, Neal TJ, Kaye SB. The use of Voriconazole in treatment of Aspergillus fumigates keratitis. Br J Ophthalmol 2007; 1095-6.
22. Deng SX, Kamal MK, Hollander DA. The use of Voriconazole in treatment of post- penetrating keratoplasty Paecilomyces keratitis. J Ocul Pharmacol Ther 2009; 25: 175-8.
23. Baron DD, Ares R, Peralba T, Sanchez P, Jung R, Barcia M. Use of topical Voriconazole in fungal keratitis. Arc Sof Esp Oftalmol 2008; 83: 493-6.
24. Barron BA, Gee L, Hauck WW etal. Herpetic Eye Disease Study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1871-82.
25. Forbes BA, Sahm DF, Weissfeild AS. Laboratory methods in basic mycology. Bailey and Scoff's Diagnostic Microbiology, 11th edn. St. Louis: Mosby, 2002; 711-98.
26. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Wim WC. Colour Atlas and Textbook of Diagnostic Microbiology, 5th edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 1997; 983-1057.
27. Gonzales CA, Srinivasan M, Witcher JP, Smolin G. Incidence of corneal ulceration in Madurai district, south India. Ophthalmic Epidemiol 1996; 3: 159-66.
28. Panda A, Sharma N, Das G, Kumar N, Satpathy G. Mycotic keratitis in children: epidemiologic and microbiological evaluation. Cornea 1997; 16: 295-99.
29. Bharathi MJ, Ramakrishnan R, Vasu S etal. Epidemiological characteristics and laboratory diagnosis of fungal keratitis: a three-year study. Indian J Ophthalmol 2003; 51: 315-21.
30. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003; 16: 730-97.
31. Vemulaconda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. Aqueous and vitreous concentration following topical administration of 1% voriconazole in humans. Arch Ophthalmol 2008; 126: 18-22.
32. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in treatment of fungal eye infections: a review. Br J Ophthalmol 2008; 98: 871-8.
33. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007; 51: 239-44.